Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2019

View Archived Issues

Identification of PDE10A inhibitors with potential application in schizophrenia

Phase III data demonstrates equivalence between SB8 and bevacizumab in terms of best ORR

Shanghai Fochon Pharmaceutical, Fochon Pharmaceuticals patent TRK inhibitors

Development of novel sclerostin-resistant mouse model of T1D

Symphogen presents early clinical data for Sym-015 in advanced solid tumors

Results presented from phase III SANET-ep study of surufatinib

First-in-human study of apramycin

GlaxoSmithKline initiates phase I study of GSK-2904545A vaccine candidate

CAR-iNKT cells safe and active in neuroblastoma patients

Preclinical results for IKS-01, a next-generation ADC with antitumor activity

Escalier Biosciences describes new RORgammaT modulators

Mavupharma presents E-NPP1 inhibitors

Peptide Logic awarded NIH HEAL initiative grant

New GBP1 and/or GBP1/PIM1 interaction inhibitors discovered at Stanford University

Arbutus Biopharma patents HBsAg secretion inhibitors

Keeping score by DRUP, not in dribs and drabs

Shire Human Genetic Therapies presents new kallikrein B inhibitors

Main function of Parkinson's gene is in inflammation

FDA approves Aklief cream for topical treatment of acne

GSK begins first-in-human study of rabies vaccine GSK-3903133A

Positive phase II data presented for lurbinectedin in malignant pleural mesothelioma

ReveraGen presents 18-month data on vamorolone in Duchenne muscular dystrophy

Kodiak begins phase II study of KSI-301 for wet AMD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...